| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.0098 | 1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |